Neocortical localization and thalamocortical modulation of neuronal hyperexcitability contribute to Fragile X Syndrome

Commun Biol. 2022 May 11;5(1):442. doi: 10.1038/s42003-022-03395-9.

Abstract

Fragile X Syndrome (FXS) is a monogenetic form of intellectual disability and autism in which well-established knockout (KO) animal models point to neuronal hyperexcitability and abnormal gamma-frequency physiology as a basis for key disorder features. Translating these findings into patients may identify tractable treatment targets. Using source modeling of resting-state electroencephalography data, we report findings in FXS, including 1) increases in localized gamma activity, 2) pervasive changes of theta/alpha activity, indicative of disrupted thalamocortical modulation coupled with elevated gamma power, 3) stepwise moderation of low and high-frequency abnormalities based on female sex, and 4) relationship of this physiology to intellectual disability and neuropsychiatric symptoms. Our observations extend findings in Fmr1-/- KO mice to patients with FXS and raise a key role for disrupted thalamocortical modulation in local hyperexcitability. This systems-level mechanism has received limited preclinical attention but has implications for understanding fundamental disease mechanisms.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Female
  • Fragile X Mental Retardation Protein / genetics
  • Fragile X Syndrome* / genetics
  • Humans
  • Intellectual Disability*
  • Mice
  • Mice, Knockout
  • Neocortex*

Substances

  • FMR1 protein, human
  • Fmr1 protein, mouse
  • Fragile X Mental Retardation Protein

Associated data

  • figshare/10.6084/m9.figshare.19424015.v13